期刊论文详细信息
Trials
Six weeks of home enteral nutrition versus standard care after esophagectomy or total gastrectomy for cancer: study protocol for a randomized controlled trial
Karen Smith2  Ruth Pulikottil-Jacob5  Anne L Thomas3  Vanessa Halliday1  Melanie Baker4  David J Bowrey4 
[1] School of Health and Related Research, University of Sheffield, 30 Regent St, Sheffield S1 4DA, UK;Department of Health Sciences, University of Leicester, 22-28 Princess Rd West, Leicester LE1 6TP, UK;Department of Oncology, Clinical Sciences Building, University of Leicester, Leicester LE1 5WW, UK;Department of Surgery, University Hospitals of Leicester NHS Trust, Level 6 Balmoral Building, Leicester Royal Infirmary, Leicester LE1 5WW, UK;Department of Health Economics, Room A101, University of Warwick, Warwick CV4 7AL, UK
关键词: Esophagectomy;    Esophageal cancer;    Qualitative;    Jejunostomy;    Gastric cancer;    Gastrectomy;    Feasibility;    Enteral nutrition;   
Others  :  805701
DOI  :  10.1186/1745-6215-15-187
 received in 2014-01-07, accepted in 2014-05-09,  发布年份 2014
PDF
【 摘 要 】

Background

Each year approximately 3000 patients in the United Kingdom undergo surgery for esophagogastric cancer. Jejunostomy feeding tubes, placed at the time of surgery for early postoperative nutrition, have been shown to have a positive impact on clinical outcomes in the short term. Whether feeding out of hospital is of benefit is unknown. Local experience has identified that between 15 and 20% of patients required ‘rescue’ jejunostomy feeding for nutritional problems and weight loss while at home. This weight loss and poor nutrition may contribute to the detrimental effect on the overall quality of life (QoL) reported in these patients.

Methods/Design

This randomized pilot and feasibility study will provide preliminary information on the routine use of jejunostomy feeding after hospital discharge in terms of clinical benefits and QoL. Sixty participants undergoing esophagectomy or total gastrectomy will be randomized to receive either a planned program of six weeks of home jejunostomy feeding after discharge from hospital (intervention) or treatment-as-usual (control). The intention of this study is to inform a multi-centre randomized controlled trial. The primary outcome measures will be recruitment and retention rates at six weeks and six months. Secondary outcome measures will include disease specific and general QoL measures, nutritional parameters, total and oral nutritional intake, hospital readmission rates, and estimates of healthcare costs. Up to 20 participants will also be enrolled in a qualitative sub-study that will explore participants’ and carers’ experiences of home tube feeding.

The results will be disseminated by presentation at surgical, gastroenterological and dietetic meetings and publication in appropriate peer review journals. A patient-friendly lay summary will be made available on the University of Leicester and the University Hospitals of Leicester NHS Trust websites. The study has full ethical and institutional approval and started recruitment in July 2012.

Trial registration

UKClinical Research Network ID #12447 (Main study); UKCRN ID#13361 (Qualitative sub study); ClinicalTrials.gov #NCT01870817 (First registered 28 May 2013)

【 授权许可】

   
2014 Bowrey et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140708082409207.pdf 296KB PDF download
Figure 2. 45KB Image download
【 图 表 】

Figure 2.

【 参考文献 】
  • [1]UK Esophageal Cancer Statistics [http://info.cancerresearchuk.org/cancerstats/types/oesophagus/?a=5441 webcite]
  • [2]Sharpe D, Williams RN, Ubhi SS, Sutton CD, Bowrey DJ: The “two-week wait” referral pathway allows prompt treatment but does not improve outcome for patients with oesophago-gastric cancer. Eur J SurgOncol 2010, 36:977-981.
  • [3]Weimann A, Braga M, Harsanyi L, Laviano A, Ljungqvist O, Soeters P: ESPEN guidelines on Enteral Nutrition: Surgery including organ transplantation. Clin Nutr 2006, 25:224-244.
  • [4]Sikora SS, Ribeiro U, Kane JM, Landreneau RJ, Lembersky B, Posner MC: Role of nutrition support during induction chemoradiation therapy in esophageal cancer. J Parenter Enteral Nutr 1998, 22:18-21.
  • [5]Barlow R, Price P, Reid TR, Hunt S, Clark GWB, Havard TJ: Prospective multicentredrandomized controlled trial of early enteral nutrition for patients undergoing major upper gastrointestinal surgical resection. Clin Nutr 2011, 30:560-566.
  • [6]Bozzetti F, Braga M, Gianotti L, Gavazzi C, Mariani L: Postoperative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomized multi-centred trial. Lancet 2001, 358:1487-1492.
  • [7]National Esophagogastric Cancer Audit: An audit of the care received by patients with Esophagogastric cancer in England and Wales [http://www.hscic.gov.uk/og webcite]
  • [8]Murphy PM, Modi P, Rahamim J, Wheatley T, Lewis SJ: An investigation into the current peri-operative nutritional management of esophageal carcinoma patients in major carcinoma centers in England. Surg Oncol 2006, 88:35-362.
  • [9]Tomaszek SC, Cassivi SD, Allen MS, Shen R, Nichols FC, Deschamps C, Wigle DA: An alternative postoperative pathway reduces length of hospitalisation following esophagectomy. Eur J Cardiothorac Surg 2010, 37:807-813.
  • [10]Haverkort EB, Binnekade JM, De Hann RJ, Busch ORC, Van Berge Henegouwen M, Gouma DJ: Suboptimal Intake of Nutrients after Esophagectomy with Gastric Tube Reconstruction. J Acad Nutr Diet 2012, 112:1081-1087.
  • [11]Couper G: Jejunostomy after Esophagectomy: A review of evidence and current practice. Proc Nutr Soc 2011, 70:316-320.
  • [12]Hyltander A, Bosaeus I, Svedlund J, Liedman B, Hugosson I, Wallengren O, Olsson U, Johnsson E, Kostic S, Henningsson A, Korner U, Lundell L, Lundholm K: Supportive Nutrition on Recovery of Metabolism, Nutritional State, Health-related Quality of Life, and Exercise Capacity After Major Surgery: A Randomised Study. Clin Gastroenterol Hepatol 2005, 3:466-474.
  • [13]Macharg FMS, Huddy JR, Priest OH, Preston SR: Extended enteral nutrition via feeding jejunostomy reduces weight loss and readmission following esophagectomy. Dis Esophagus 2012, 25:48A.
  • [14]Ryan AM, Rowley SP, Healy LA, Flood PM, Ravi N, Reynolds JV: Post-esophagectomy early enteral nutrition via a needle catheter jejunostomy: 8-year experience at a specialist unit. Clin Nutr 2006, 25:386-393.
  • [15]Martin L, Lagergren J, Lindblad M, Rouvelas I, Lagergren P: Malnutrition after esophageal cancer surgery in Sweden. Br J Surg 2007, 94:1496-1500.
  • [16]Ludwig DJ, Thirlby RC, Low DE: A prospective evaluation of dietary status and symptoms after near-total esophagectomy without gastric emptying procedure. Am J Surg 2001, 181:454-458.
  • [17]Blazeby JM, Farndon JR, Donovan J, Alderson D: A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 2000, 88:1781-1787.
  • [18]Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME: Cancer: disease and nutrition are key determinants of patient’s quality of life. Support Care Cancer 2004, 12:246-252.
  • [19]Carey S, Storey D, Biankin AV, Martin D, Young J, Alllman F: Long term nutritional status and quality of life following major upper gastrointestinal surgery – A cross sectional study. Eur J Clin Nutr 2011, 30:774-779.
  • [20]Brotherton AM, Judd PA: Quality of life in adult enteral tube feeding patients. J Hum Nutr Diet 2007, 20:513-522.
  • [21]Brotherton A, Abbott J, Aggett P: The impact of percutaneous endoscopic gastrostomy feeding upon daily life in adults. J Hum Nutr Diet 2006, 19:355-367.
  • [22]Jordon S, Philpin S, Warring J, Cheung WY, Williams J: Percutaneous endoscopic gastrostomies: the burden of treatment from a patient perspective, Issues and innovations in nursing practice. J Adv Nurs 2006, 56:270-281.
  • [23]Henry CJ: Basal metabolic rate studies in humans: measurement and development of new equations. Public Health Nutr 2005, 8:1133-1152.
  • [24]Department of Health: Dietary Reference Values for food energy and nutrients for the United Kingdom. London: HMSO; 1991.
  • [25]Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flectner H, Fleishman B, De Haes JCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F: The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Canc Inst 1993, 85:365-376.
  • [26]Lagergren P, Fayers P, Conroy T, Stein HJ, Sezer O, Hardwick R, Hammerlid E, Bottomley A, Van Cutsem E, Blazeby JM: Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach. Eur J Cancer 2007, 43:2066-2073.
  • [27]Glaser B, Strauss A: The discovery of grounded theory. Hawthorne, New York: Aldine Publishing Company; 1967.
  • [28]Strauss A, Corbin J: Grounded theory methodology: An overview. In Handbook of qualitative research. Edited by Denzin NK, Lincoln YS. Thousand Oaks CA: Sage; 1994:273-285.
  • [29]McKenzie L, van der Pol M: Mapping the EORTC QLQ-C30 onto the EQ-5D instrument: the potential to estimate QALYs without generic preference data. Value Health 2009, 12:167-171.
  文献评价指标  
  下载次数:6次 浏览次数:18次